Therapeutic foam technology
Total Trials
1
As Lead Sponsor
As Collaborator
0
Total Enrollment
40
NCT02880163
REVIVE: Reducing Exsanguination Via In-Vivo Expandable Foam
Phase: N/A
Role: Lead Sponsor
Start: Jun 28, 2024
Completion: Jul 28, 2025
Loading map...